Procollagen-positive fibroblasts predominantly express fibrogenic growth factors and their receptors in human encapsulation process against foreign body

Journal of Pathology

Volumn 186, Issue 2, 1998, Pages 201-208

  Katou, Fuminori ^a   Ohtani, Haruo ^b   Nagura, Hiroshi ^b   Motegi, Katsutoshi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Double immunohistochemistry; Encapsulation; Foreign body; Mandible; PDGF; Receptor; TGF ; Titanium miniplate

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; ENCAPSULATION; FIBROBLAST; FIBROGENESIS; FOREIGN BODY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MANDIBLE FRACTURE; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; BONE PLATES; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; FOREIGN-BODY REACTION; HUMANS; IMMUNOENZYME TECHNIQUES; MANDIBLE; MIDDLE AGED; PERIOSTEUM; PLATELET-DERIVED GROWTH FACTOR; PROCOLLAGEN; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031720543     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(1998100)186:2<201::AID-PATH157>3.0.CO;2-C     Document Type: Article

References (33)

1. Shanbhag AS, Jacobs JJ, Black J, Galante JO, Giant TT. Macrophage/ particle interactions: effect of size, composition and surface area. J Biomed Mater Res 1994; 28: 81-90.
2. Lalor PA, Revell PA. T-lymphocytes and titanium aluminium vanadium (TiAlV) alloy. Evidence for immunological events associated with debris deposition. Clin Mater 1993; 12: 57-62.
3. Miyazono K, Heldin C-H. Structure, function and possible clinical application of transforming growth factor-β. J Dermatol 1992; 19: 644-647.
4. Bassols A. Massagué J. Transforming growth factor β regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem 1988; 263: 3039-3045.
5. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987; 6: 1899-1904.
6. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986; 46: 155-169.
7. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987; 105: 1039-1045.
8. Pierce GF, Mustoe TA, Lingelbach J, et al. Platelet-derived growth factor and transforming growth factor-β enhance tissue repair activities by unique mechanisms. J Cell Biol 1989; 109: 429-440.
9. Clark JG, Madtes DK, Raghu G. Effects of platelet-derived growth factor isoforms on human lung fibroblast proliferation and procollagen gene expression. Exp Lung Res 1993; 19: 327-344.
10. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J Exp Med 1987; 165: 251-256.
11. Wakefield LM, Smith DM, Masui T, Harris CC, Sporn MB. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 1987; 105: 965-975.
12. Fine A, Goldstein RH. The effect of transforming growth factor-β on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem 1987; 262: 3897-3902.
13. Mustoe TA, Pierce GF, Morishima C, Deuel TF. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest 1991; 87: 694-703.
14. Katou F, Motegi K. Fixation of mandibular body fracture with combination of one-piece cast splint and miniplate. Tohoku J Exp Med 1995; 175: 111-121.
15. Taketazu F, Kato M, Gobl A, et al. Enhanced expression of transforming growth factor-βs and transforming growth factor-β type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab Invest 1994; 70: 620-630.
16. Waltenberger J, Lundin L, Öberg K, et al. Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol 1993; 142: 71-78.
17. Franzén P, ten Dijke P, Ichijo H, et al. Cloning of a TGF β type I receptor that forms a heteromeric complex with the TGF β type II receptor. Cell 1993; 75: 681-692.
18. Yamada N, Kato M, Yamashita H, et al. Enhanced expression of transforming growth factor-β and its type I and type II receptors in human glioblastoma. Int J Cancer 1995; 62: 386-392.
19. Pinzani M, Milani S, Herbst H, et al. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J pathol 1996; 148: 785-800.
20. Mizoi T, Ohtani H, Miyazono K, et al. Immunoelectron microscopic localization of transforming growth factor β1 and latent transforming growth factor β1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells. Cancer Res 1993; 53: 183-190.
21. McDonald JA, Broekelmann TJ, Matheke ML, et al. A monoclonal antibody to the carboxyterminal domain of procollagen type I visualizes collagen-synthesizing fibroblasts. Detection of an altered fibroblast phenotype in lungs of patients with pulmonary fibrosis. J Clin Invest 1986; 78: 1237-1244.
22. Pierce GF, Tarpley JE, Allman RM, et al. Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB. Am J Pathol 1994; 145: 1399-1410.
23. Roberts AB, Sporn MB. The transforming growth factor-βs. In: Roberts AB, Sporn MB, eds. Peptide Growth Factors and Their Receptors I. Berlin: Springer-Verlag, 1990; 419-472.
24. Frank S, Madlener M, Werner S. Transforming growth factor β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 1996; 271: 10 188-10 193.
25. Cox DA. Transforming growth factor-beta 3. Cell Biol Int 1995; 19: 357-371.
26. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995; 108: 985-1002.
27. Chen R-H, Ebner R, Derynck R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 1993; 260: 1335-1338.
28. Zhao Y, Young SL. Requirement of transforming growth factor-β (TGF-β) type II receptor for TGF-β-induced proliferation and growth inhibition. J Biol Chem 1996; 271: 2369-2372.
29. Gold LI, Sung JJ, Siebert JW, Longaker MT. Type I (RI) and type II (RII) receptors for transforming growth factor-β isoforms are expressed subsequent to transforming growth factor-β ligands during excisional wound repair. Am J Pathol 1997; 150: 209-222.
30. Pierce GF, Tarpley JE, Tseng J, et al. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest 1995; 96: 1336-1350.
31. Reuterdahl C, Sundberg C, Rubin K, Funa K, Gerdin B. Tissue localization of β receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans. J Clin Invent 1993; 91: 2065-2075.
32. Katou F, Andoh N, Motegi K, Nagura H. Immuno-inflammatory responses in the tissue adjacent to titanium miniplates used in the treatment of mandibular fractures. J Cranio-Maxillofac Surg 1996; 24: 155-162.
33. Manlapaz M, Maloney WJ, Smith RL. In vitro activation of human fibroblasts by retrieved titanium alloy wear debris. J Orthop Res 1996; 14: 465-472.